Tumor Fibrin or Fibrinogen Matrix as a Unique Therapeutic Target for Pulmonary Cancer Growth and Metastases - Abstract
The causes for the death of cancer patients’ deaths can be multi-factorials and pathogenesis progresses in clinics. Apart from direct causes from tumor progressions and metastases by genetic inheritance, mutations, deletions, repeating and other types of genetic dysfunction, other clinical complications or factors will more or less speed up the deaths of cancer patients. The cancer assistant therapies have be renewed to be the major forces for improving therapeutic actions for inhibiting cancer complications in clinics. Pulmonary cancer is one of the highest incidence and mortality characteristics cancer categories for complicate disease progression worldwide. This mini-review discusses one of these complicating factors and possible mechanisms of action and therapeutic solutions are given.